198 related articles for article (PubMed ID: 21785031)
1. Use of pure opioid antagonists for management of opioid-induced pruritus.
Miller JL; Hagemann TM
Am J Health Syst Pharm; 2011 Aug; 68(15):1419-25. PubMed ID: 21785031
[TBL] [Abstract][Full Text] [Related]
2. A naloxone admixture to prevent opioid-induced pruritus in children: a randomized controlled trial.
West N; Ansermino JM; Carr RR; Leung K; Zhou G; Lauder GR
Can J Anaesth; 2015 Aug; 62(8):891-900. PubMed ID: 25902891
[TBL] [Abstract][Full Text] [Related]
3. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.
Rosow CE; Gomery P; Chen TY; Stefanovich P; Stambler N; Israel R
Clin Pharmacol Ther; 2007 Jul; 82(1):48-53. PubMed ID: 17392726
[TBL] [Abstract][Full Text] [Related]
4. Opioid antagonists in the treatment of opioid-induced constipation and pruritus.
Friedman JD; Dello Buono FA
Ann Pharmacother; 2001 Jan; 35(1):85-91. PubMed ID: 11197589
[TBL] [Abstract][Full Text] [Related]
5. The optimal dose of prophylactic intravenous naloxone in ameliorating opioid-induced side effects in children receiving intravenous patient-controlled analgesia morphine for moderate to severe pain: a dose finding study.
Monitto CL; Kost-Byerly S; White E; Lee CK; Rudek MA; Thompson C; Yaster M
Anesth Analg; 2011 Oct; 113(4):834-42. PubMed ID: 21890885
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial.
Paech M; Sng B; Ng L; Nathan E; Sia A; Carvalho B
Br J Anaesth; 2015 Mar; 114(3):469-76. PubMed ID: 25567476
[TBL] [Abstract][Full Text] [Related]
7. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.
Firouzian A; Gholipour Baradari A; Alipour A; Emami Zeydi A; Zamani Kiasari A; Emadi SA; Kheradmand B; Hadadi K
J Neurosurg Anesthesiol; 2018 Jan; 30(1):26-31. PubMed ID: 27673505
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
Merchan C; Altshuler D; Papadopoulos J
Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
[TBL] [Abstract][Full Text] [Related]
10. Methylnaltrexone for opioid-induced constipation.
Belavic JM
Nurse Pract; 2009 Mar; 34(3):6-7. PubMed ID: 19240629
[No Abstract] [Full Text] [Related]
11. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study.
Maxwell LG; Kaufmann SC; Bitzer S; Jackson EV; McGready J; Kost-Byerly S; Kozlowski L; Rothman SK; Yaster M
Anesth Analg; 2005 Apr; 100(4):953-958. PubMed ID: 15781505
[TBL] [Abstract][Full Text] [Related]
12. Naloxone infusion and post-hysterectomy morphine consumption: a double-blind, placebo-controlled study.
Movafegh A; Shoeibi G; Ansari M; Sadeghi M; Azimaraghi O; Aghajani Y
Acta Anaesthesiol Scand; 2012 Nov; 56(10):1241-9. PubMed ID: 22946762
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
Lee JM; Mooney J
Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
[TBL] [Abstract][Full Text] [Related]
14. [Management of adverse effects of opioid therapy].
Wirz S
Z Gastroenterol; 2017 Apr; 55(4):394-400. PubMed ID: 28363231
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.
Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572
[No Abstract] [Full Text] [Related]
16. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
[TBL] [Abstract][Full Text] [Related]
18. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
19. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
Kumar N; Garg N; Bailey A
J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399
[No Abstract] [Full Text] [Related]
20. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
